2-Bromo-5-(1,2-oxazol-3-yl)-1,3,4-thiadiazole

Catalog No. :
ACJRNR561
CAS No. :
1342234-81-4
Molecular Formula :
C5H2BrN3OS
Molecular Weight :
232.06

IUPAC Name:3-(5-bromo-1,3,4-thiadiazol-2-yl)isoxazole

2-Bromo-5-(1,2-oxazol-3-yl)-1,3,4-thiadiazole structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg95%$305.00Login to see priceInquiryInquiry
100mg95%$446.00Login to see priceInquiryInquiry
250mg95%$627.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-Bromo-5-(1,2-oxazol-3-yl)-1,3,4-thiadiazole
IUPAC Name3-(5-bromo-1,3,4-thiadiazol-2-yl)isoxazole
MDL No.MFCD18345202
Molecular FormulaC5H2BrN3OS
Molecular Weight232.06
SMILESBrC1=NN=C(C2=NOC=C2)S1
InChI KeyBSBPZRPVKNMTBV-UHFFFAOYSA-N
Synonym3-(5-bromo-1,3,4-thiadiazol-2-yl)isoxazole;2-bromo-5-(1,2-oxazol-3-yl)-1,3,4-thiadiazole;1,3,4-Thiadiazole, 2-bromo-5-(3-isoxazolyl)-
CAS No.1342234-81-4

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H312-H315-H319-H332-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACJRNR561 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACKHJV123 route compound structure diagram
    ACKHJV12355981-29-8 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACJRNR561 route product structure diagram
    ACJRNR5611342234-81-4
Inquiry

2. ACJRNR561 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACSMCY815 route compound structure diagram
    ACSMCY815111454-71-8 In Stock
  2. Plus
  3. ACKHJV123 route compound structure diagram
    ACKHJV12355981-29-8 In Stock
  4. Then
  5. ACJRNR561 route product structure diagram
    ACJRNR5611342234-81-4
Inquiry

Comments (0)